INTRICON CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-12-19: Form 8-K; Period of report 2017-12-15; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 7.01 Regulation FD Disclosure; 8.01 Other Events; Details 1.01.
- 2017-11-06: Form 8-K; Period of report 2017-11-06; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
- 2017-08-02: Form 8-K; Period of report 2017-08-02; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
- 2017-06-22: Form 8-K; Period of report 2017-06-22; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-12-19 | 8-K | 2017-12-15 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 7.01 Regulation FD Disclosure; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 2.03 Amendment of Loan and Security Agreement. 7.01 A copy of the Company’s press release issued in connection with the matters described in this Current Report on Form 8-K is furnished herewith as Exhibit 99.1. 8.01 On December 18, 2017, the Company announced that it had completed the acquisition of Hearing Help Express, Inc. (“HHE”), acquiring the remaining 80-percent stake of the DeKalb, Ill.-based, direct-to-consumer mail order hearing aid provider. | intricon173370_8k.htm |
| 2017-11-06 | 8-K | 2017-11-06 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The following information is being provided pursuant to Item 2.02. 7.01 The following information is being provided pursuant to Item 7.01. | intricon172997_8k.htm |
| 2017-08-02 | 8-K | 2017-08-02 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The following information is being provided pursuant to Item 2.02. 7.01 The following information is being provided pursuant to Item 7.01. | intricon172178_8k.htm |
| 2017-06-22 | 8-K | 2017-06-22 | 7.01 Regulation FD Disclosure | 7.01 On June 22, 2017, IntriCon Corporation (the “Company”) issued a press release (the “Press Release”) announcing (i) the completion of the introduction of its advanced digital hearing devices into Hearing Help Express’ (HHE) product line and (ii) that management is unaware of any reason why the Company stock has experienced a recent price decrease. | intricon171822_8k.htm |
| 2017-05-02 | 8-K | 2017-04-27 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 (a) The Annual Meeting of Shareholders of IntriCon was held on April 27, 2017. | intricon171400_8k.htm |
| 2017-04-25 | 8-K | 2017-04-25 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The following information is being provided pursuant to Item 2.02. 7.01 The following information is being provided pursuant to Item 7.01. | intricon171286_8k.htm |
| 2017-02-21 | 8-K | 2017-02-17 | 7.01 Regulation FD Disclosure | 7.01 On February 17, 2017, IntriCon Corporation completed the sale of the assets of its cardiac diagnostic monitoring business to Datrix, LLC. | intricon170455_8k.htm |
| 2017-02-16 | 8-K | 2017-02-16 | 2.02 Results of Operations and Financial Condition; 2.05 Costs Associated with Exit or Disposal Activities; 2.06 Material Impairments; 7.01 Regulation FD Disclosure | 2.02 The following information is being provided pursuant to Item 2.02. 2.05 On December 30, 2016, the Board of Directors of the Company approved the divestiture of the Company’s cardiac diagnostic monitoring business (the “CDM Business”) and authorized management to begin a sale process. 2.06 The information set forth above in Item 2.05 is hereby incorporated into Item 2.06 by reference. 7.01 The following information is being provided pursuant to Item 7.01. | intricon170443_8k.htm |